The SIL1 gene helps cells fold newly made proteins correctly inside the endoplasmic reticulum, a part of the cell that processes proteins. When this gene does not work well, misfolded proteins can build up and place stress on cells, especially in the brain, muscles, and the lens of the eye. The protein made by this gene helps your cells keep this protein handling system running smoothly. Harmful variants in both copies of the SIL1 gene are a known cause of Marinesco-Sjögren syndrome, which often includes early cataracts, muscle weakness, balance problems, and developmental delay.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to go deeper into this topic, you can find more in the LearnHub.
Overview
SIL1Gene function
What if the gene works
The SIL1 gene helps cells fold proteins into the right shape inside the endoplasmic reticulum, a protein processing area. This supports healthy muscle, nerve, and eye function.
Risk
What if the gene does not work
More severe variants in the SIL1 gene can cause Marinesco-Sjögren syndrome, with cataracts, muscle weakness, and delayed development. Milder variants may change when features appear and how strongly movement and learning are affected.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the SIL1 gene, no SIL1-specific treatment or drug selection approach is currently established.
Conditions associated with SIL1
Gene function
What if the gene works
Inside many cells, the SIL1 gene helps newly made proteins take on the right shape before they are used or released. This work happens in the endoplasmic reticulum, a cell compartment that prepares proteins for the rest of the body. Understanding what the SIL1 gene does in the body helps explain how cells keep their protein supply organized and usable.
The SIL1 gene helps a protein helper called BiP guide newly made proteins into the right shape. This gives cells a better chance of producing proteins that are ready to work properly.
Inside the endoplasmic reticulum, the SIL1 gene helps BiP let go of one protein and get ready to assist the next one. This reset step keeps the cell’s folding system moving in an orderly way.
By supporting normal protein handling, the SIL1 gene helps maintain steady conditions in the endoplasmic reticulum. This supports everyday cell function as proteins are folded, checked, and prepared for use.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SIL1 gene often make the SIL1 protein unstable, shortened, or unable to support protein folding inside the cell. This helps explain how variants influence the SIL1 gene's function: some changes leave partial activity, while more disruptive variants can lead to very little or no working protein. That functional difference can shape how early and how strongly Marinesco-Sjögren syndrome appears.
How variants are linked to conditions
Pathogenic variants in the SIL1 gene cause Marinesco-Sjögren syndrome, a rare inherited condition that commonly involves cataracts in childhood, muscle weakness, delayed motor development, and problems with coordination. Some people also have short stature or learning difficulties, though features can vary from person to person. In practice, when doctors look at SIL1 gene variants linked to conditions, Marinesco-Sjögren syndrome is the main well-established diagnosis.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a definitive diagnosis, particularly when several genes and environmental influences play a role. Still, in some situations, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SIL1, risk is mainly shaped by genetics rather than lifestyle. A child’s chance of having the condition is higher when both parents carry a SIL1 gene change, and there is not enough evidence to say that diet, exercise, or other everyday factors lower this risk.
Inheritance of SIL1 variants
Variants in the SIL1 gene are inherited in an autosomal recessive pattern. This means a person usually develops a SIL1 related condition only when they inherit two changed copies, one from each parent. Parents who each carry one variant often do not have symptoms, but with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial SIL1 variant. This pattern explains how SIL1 gene inheritance can recur in families even when parents seem healthy.
What does my SIL1 result mean for my family?
For families with a SIL1-related condition, parents are usually healthy carriers, and brothers or sisters may also be carriers or, less often, have the condition. Close relatives may want to learn whether the family change is present in them, especially if they are planning children. The main concern for relatives is carrier status rather than health problems in adulthood.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SIL1 variants uses a blood or saliva sample to read the SIL1 gene and look for changes linked to disease. Results may confirm a diagnosis, help clarify carrier status, or show that a variant needs more interpretation.
When should I consider getting a genetic test?
Genetic testing for the SIL1 gene may be worth considering when someone has signs of Marinesco-Sjögren syndrome, such as early cataracts, muscle weakness, poor balance, and delayed development. It can also help when this condition runs in the family or when a child has a mix of these features without a clear cause.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and on the kind of variant involved. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic finding may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes that help the body absorb, break down, transport, or respond to a drug can change how well a treatment works or how likely side effects are. This is a common reason why the same medication may feel helpful for one person, less effective for another, or cause more sensitivity in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This understanding can help support more informed and individualized treatment decisions. If you want to learn more about this topic, you can explore it further in the LearnHub.
Drugs influenced by the SIL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so questions about side effects, new symptoms, or medication changes are best discussed with your doctor.
History
SIL1 entered medical genetics through work on Marinesco-Sjögren syndrome, a rare inherited condition first described in the early 20th century from its pattern of muscle weakness, cataracts, and developmental differences. For many years, doctors recognized the syndrome by its clinical features alone. In 2005, researchers identified pathogenic variants in the SIL1 gene as a cause, giving families a clearer genetic explanation. From these first observations, research expanded steadily. That discovery helped confirm that cases once grouped only by symptoms could share the same inherited cause, and it improved genetic classification of the condition. Over time, additional reports showed that changes in SIL1 can lead to a range of features, which sharpened how clinicians recognize and diagnose this condition.